After publishing research in 2022 that compared the effectiveness of four common medications for type 2 diabetes, University of Colorado Department of Medicine faculty member Neda Rasouli, MD, and a national team of researchers decided to delve deeper into their data to help determine which medication(s) may be superior to others. The results of these secondary analyses were recently published as 10 articles in Diabetes Care. Rasouli was the first author of one of these articles and a co-author on others. These papers offer further insight into differences between the four medications—insulin glargine, liraglutide, glimepiride, and sitagliptin—to help health care Read More
No comments:
Post a Comment